Get an alert when BAUSCH & LOMB U.K. LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-11-18 (in 6mo)

Last made up 2025-11-04

Watchouts

None on the register

Cash

£5M

+151% vs 2023

Net assets

£36M

+16% vs 2023

Employees

175

+0.6% vs 2023

Profit before tax

£6M

+33.7% vs 2023

Name history

Renamed 2 times since incorporation

  1. BAUSCH & LOMB U.K. LIMITED 1983-03-21 → present
  2. BAUSCH & LOMB UK LIMITED 1976-12-31 → 1983-03-21
  3. BAUSCH & LOMB OPTICAL COMPANY,LIMITED 1916-04-28 → 1976-12-31

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £97,465,000£101,447,000
Operating profit £2,474,000£3,115,000
Profit before tax £4,428,000£5,922,000
Net profit £4,353,000£5,038,000
Cash £2,056,000£5,160,000
Total assets less current liabilities £31,583,000£36,535,000
Net assets £31,424,000£36,462,000
Equity £31,424,000£36,462,000
Average employees 174175
Wages £11,588,000£12,722,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 2.5%3.1%
Net margin 4.5%5.0%
Return on capital employed 7.8%8.5%
Current ratio 1.20x1.45x
Interest cover 8.36x16.14x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Directors prepared cash flow forecasts for the next 12 months from signing these financial statements, reflecting downside plausible scenarios, and as at the date of signing of the financial statements it is expected that the Company will have sufficient cash to meet its obligations in the ordinary course of business. The business has achieved a further increase in turnover in the first half of 2025 and is on course to grow its business further in the second half of the year. The Company is in a net current assets position as at year end, 31st December 2024 following a net current asset position for year ended, 31st December 2023. However, the entity is placing reliance on letter of support from Bausch + Lomb Corporation, which is part of the ultimate parent Company's structure and is an intermediate parent of the Company. Bausch + Lomb Corporation, intends to support the Company for at least 12 months from the date of approval of these financial statements. The Company applies going concern assumption in preparing its financial statements.”

Group structure

  1. BAUSCH & LOMB U.K. LIMITED · parent
    1. Sterimedix Limited 100% · England · manufacturer of single use ophthalmic and aesthetic medical devices

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 30 resigned

Name Role Appointed Born Nationality
KUEHNE, Eberhard Karl Heinz Director 2017-12-18 Apr 1965 German
PANDA, Manoj Kumar Director 2022-07-01 Jun 1976 American
WHITE, Jennifer Elizabeth Director 2022-07-01 Nov 1964 British
Show 30 resigned officers
Name Role Appointed Resigned
GEISEL, Jean Secretary 2009-06-30 2010-01-28
LAFAVE, John Secretary 2010-01-29 2011-11-05
OREILLY, Desmond John Secretary 2009-04-17
WHITE, Jennifer Secretary 2022-10-06 2023-07-11
DENTONS SECRETARIES LIMITED Corporate Secretary 2011-11-05 2022-10-06
BAILEY, Ambrose Robert Douglas Director 2008-02-12 2013-08-06
BROWN, John Director 2009-05-08 2010-09-30
COOKE, Simon Henry Director 1996-04-30
DETOURS, Pierre Savy Paul Marie Director 2013-08-06 2013-09-16
DOW, Duncan William Director 2017-12-18 2020-05-22
EXALL, David John Director 2013-01-24 2013-08-30
GRAFF, Robert Stuart Director 1994-07-31
HARRIS, Brian James, Director Director 2010-09-30 2013-08-06
HELLRUNG, Stephen Andrew Director 1997-05-30
HESKETH, Benjamin Harry Director 2020-05-22 2022-07-01
HURRELL, Paul Allan Director 2010-09-30 2012-12-12
JEDRZEJUK, Marcin Edward Director 2013-08-30 2017-12-14
LAGORGA, Linda Ann Director 2013-08-30 2018-04-20
LAYMAN, Randolph Evanston Director 1994-01-21
LOAN, Nicholas Warde Director 1996-12-09 2006-07-31
MORE, Janice Kathleen Mary Director 2017-06-01 2020-09-22
OREILLY, Desmond John Director 2009-04-17
OSBALDESTON, Stephen Director 1995-01-30
SOPER, Gordon Richard Morris Director 1999-04-07
STEER, Gareth Director 2006-09-07 2009-02-17
STILES, Robert Barton Director 1997-09-12 2008-02-12
WALSH, Francis James Director 1999-04-09 2009-05-14
WHALEN, David George Director 1995-03-23 1996-10-23
WOODFIELD, William Norman Director 2018-04-20 2022-07-01
ZENG, Ling Director 2013-08-30 2017-05-31

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Bausch + Lomb Corporation Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2022-05-05 Active
Bausch Health Companies Inc. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2020-01-09 Ceased 2022-05-05
Bausch & Lomb Uk Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Ceased 2020-01-09

Filing timeline

Last 20 of 217 total filings

Date Type Category Description
2026-01-08 AA accounts Accounts with accounts type full
2025-11-11 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-11-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-10-13 AA accounts Accounts with accounts type full
2023-11-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-10-16 AA accounts Accounts with accounts type full
2023-08-30 TM02 officers Termination secretary company with name termination date PDF
2022-12-01 AP03 officers Appoint person secretary company with name date PDF
2022-11-23 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2022-11-23 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2022-11-23 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-10-17 AA accounts Accounts with accounts type full
2022-10-10 TM02 officers Termination secretary company with name termination date PDF
2022-07-14 AP01 officers Appoint person director company with name date PDF
2022-07-13 TM01 officers Termination director company with name termination date PDF
2022-07-13 TM01 officers Termination director company with name termination date PDF
2022-07-13 AP01 officers Appoint person director company with name date PDF
2022-06-22 MR04 mortgage Mortgage satisfy charge full PDF
2022-06-22 MR04 mortgage Mortgage satisfy charge full PDF
2022-06-22 MR04 mortgage Mortgage satisfy charge full PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page